Fuan Pharmaceutical announced that its wholly-owned subsidiary Tianheng Pharmaceutical recently received a drug registration certificate for bromhexine hydrochloride injection issued by the State Drug Administration. The specification is 2 ml: 4 mg. The drug is suitable for patients who have difficulty administering it orally and have sticky phlegm and are difficult to cough up. Currently, a total of 30 companies have passed the consistency evaluation or acceptance. Obtaining a certificate will enrich the subsidiary's product line and enhance competitiveness, but there is uncertainty about product production, sales, and the impact on performance.

Fuan Pharmaceutical announced that its wholly-owned subsidiary Tianheng Pharmaceutical recently received a drug registration certificate for bromhexine hydrochloride injection issued by the State Drug Administration. The specification is 2 ml: 4 mg. The drug is suitable for patients who have difficulty administering it orally and have sticky phlegm and are difficult to cough up. Currently, a total of 30 companies have passed the consistency evaluation or acceptance. Obtaining a certificate will enrich the subsidiary's product line and enhance competitiveness, but there is uncertainty about product production, sales, and the impact on performance.